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Abstract. The use of d-amphetamine pellet implantation as a method for 
producing rapid central drug tolerance was investigated. Mice were implanted with 
d-amphetamine pellets containing 2 mg of drug and were challenged 24 h later, 
a time when no detectable drug was present, with various doses of d-amphetamine 
i.p. Implantation was found to potentiate the stereotyped activity and produced 
tolerance to the exploratory activity induced by d-amphetamine. Daily pellet 
implantation for 3 days was not found to produce tolerance to the stereotyped 
activities. Animals administered a single pellet showed no difference in the brain 
disposition or metabolism of a subsequent dose of SH-d-amphetamine. Twenty-four 
hour pellet implantation markedly increased the rate of conversion of aH-tyrosine 
to SH-dopamine (330~ and ~H-norepinephi'ine (61 ~ ) in the subcortex. However, 
this effect was reversed by the administration of 10 mg/kg of d-amphetamine. 
.Key words: d-Amphetamine -- Pellet -- Implantation -- Tolerance -- Loco- 
motor -- Activity -- Exploratory Activity -- Cateeholamines. 
Although there are a number of reports concerning tolerance to the 
anorexic effect of d-amphetamine (Harrison et al., 1953; Brodie er al., 
1969, 1970; Kasman and Unna, 1967), much less is known of tolerance 
mechanisms to the drug's central stimulant effect. Kalant (1966) has 
reported case histories where apparent tolerance developed to the stimu- 
lant action of d-amphetamine. However, this phenomena has not been 
shown to occur in laboratory animals. Recently, it was demonstrated 
that  repeated injections of d-amphetamine to mice produced habituation, 
i.e., decreased responsiveness but not tolerance (a shift in the dose- 
response curve) to certain psychomotor behavior facilitated by d-amphet- 
amine (Hitzemann and Loh, 1972). Somewhat similar results in attempt- 
ing to produce tolerance to amphetamine's stimulant effects have been 
described by Lewander (1971). 
The present experiments were undertaken to evaluate a new approach 
to produce tolerance to the centrally mediated locomotor behaviors 
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increased b y  d -amphe tamine .  The techn ique  t e s ted  involves  the  s.c. 
i m p l a n t a t i o n  of  a smal l  pel le t  conta in ing d -amphe tamine .  A t  a p p r o p r i a t e  
t imes  af te r  imp lan ta t ion ,  t he  effects of  chal lenging doses of d -amphe t -  
amine  on p sychomoto r  behav io r  were eva lua ted .  I n  addi t ion ,  the  pos- 
s ib i l i ty  t h a t  t he  observed  effects of pel le t  i m p l a n t a t i o n  on behav ior  were 
re la ted  to  differences in drug  disposi t ion  or in b ra in  ea techolamine  
me tabo l i sm was inves t iga ted .  
Mater ia ls  and Methods 
Materials. d-Amphetamine pellets were kindly prepared by Dr. Robert Gibson, 
University of California School of Pharmacy, San Francisco, California. The for- 
mulation of the pellet was 148 mg microcrystalline cellulose, 2.0 mg d-amphet- 
amine, tiC1 calculated as base, 0.75 mg fused silicone dioxide, and 0.75 mg calcium 
stearate. Placebo pellets were of similar composition but lacked d-amphetamine. 
all-d-amphetamine (general label, specific activity 1 Ci/mmol) was obtained from 
New England Nuclear Corp., Boston, Mass. 3H-tyrosine (2',3"-side chain label, 
specific activity 11.4 Ci/mmol) was obtained from Amersham-Searle Corp., Chicago, 
Ill. d-Amphetamine and p-hydroxyamphetamine were a gift of Smith, Kline and 
French Laboratories, Philadelphia, Pa. l~orephedrine and p-hydroxynorephedrine 
were purchased from Aldrich Chemical Co., Milwaukee, Wisconsin. All other reagents 
were obtained from standard suppliers. 
Experimental. Male CF l mice (Carworth Farms, Portage, Michigan) weighing 
20--22 g were used one week after acclimatization. Lighting conditions were main- 
tained exactly as they were with the supplier, i.e., lights on at 7 A.M. and ligths 
off at 7 P.M. Room temperature was maintained at 72~ Mice to be implanted 
with pellets were placed in individual cages several hour before and maintained in 
isolated conditions throughout the experimental period. The pellets were implanted 
s.c. by first pinching the skin on the back of the mouse, cutting a small hole with 
scissors at the base of the fingers and then inserting the pellet. This innocuous 
procedure can be done easily in restrained animals after sufficient surgical skill has 
been acquired. No general anesthesia is necessary. Throughout the entire period 
food and water were provided ad libitum. All control animals were implanted with 
a placebo pellet. 
Twenty-four hour after pellet implantation, animals were administered i.p. 
various doses of d-amphetamine suffate (calculated as base) dissolved in distilled 
water. Motor activity was then assessed by one of the methods described below. 
In some experiments, 0.5 h after the injection of d-amphetamine, animals were 
administered 1 ~Ci/g body weight of aH-tyrosine. Animals were sacrificed 15 and 
30 rain later by decapitation and the brains removed. The cortex and cerebellum 
were dissected away and the remainder of the brain, the diencephalon-midbrain- 
brain stem (DMB), was frozen at --40~ until analysis, which was performed 
within 48 h. The DMB tissue obtained from two animals was pooled for each 
determination of endogenous and aH-tyrosine and catecholamines. In other experi- 
ments, the effects of pellet implantation per se on motor activity and brain amines 
were determined. For catecholamine and amphetamine determinations, animals 
were sacrificed every 2 h after pellet implantation, brains removed, and the whole 
brain was frozen until analysis. The pellet was carefully removed from the carcass 
to determine residual pellet amphetamine levels. 
Motor Activity. Motor activity or various components of the activity repertoire 
were measured in two different ways. The first employed a simple open field appara- 
tus (Newton and Levine, 1968; Gupta and Holland, 1972). The open field consisted 
of a regular cage (15 • 45 cm) with a grid of 20 squares placed in the bottom. The mice 
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were removed from the individual cages and placed in the middle of the grid. 
~[otor activity was measured for 90 sec according to two criteria: One count was 
registered for every square completely crossed via forward locomotion and one 
count was registered for every rearing movement. Stereotyped behavior was 
measured during the same interval as the time the animal spent in highly repetitive 
licking, grooming and short distance (<  one grid square) locomotive behaviors. 
The testing rooms were completely dark except for a 20 watt lamp positioned 
2 feet above the open field. Animals tested in the daytime were not exposed to 
darkness for more than one-half hour before testing. The open field test was scored 
by a naive observer in a double-blind arrangement. 
The second method of measuring motor activity utilized the Pharmacia M/P Fc 
motility meter. This meter consists of 40 photocells (8 • 5) covered by a sheet of 
plexiglass and arranged such that a standard clear plastic laboratory cage exactly 
fits the photocell design. The photocells were activated by standard laboratory 
lighting during the day and a 20 watt bulb during the night. One count is registered 
for every photocell contact broken. 
Catecholamine and Tyrosine Determination. The proceduies used to isolate 
endogenous and 8tt-DA, NE and tyrosine have been described in detail elsewhere 
(Hitzemann and Loh, 1972b). After homogenization in 0.4 N HCIO~ and centrifuga- 
tion, the catechol and non-cateehol metabolites in the supernatant were separated 
by batch alumina absorption (Anton and Sayre, 1962). The non-catechol fraction 
was analyzed for endogenous and 3H-tyrosine as described by Weiner and Rabadjija 
(1968). Cateehols were eluted from the alumina with 0.2 N acetic acid and a portion 
was used for the determination of endogenous DA and NE (Ansell and Beeson, 
(1968). To the remainder of the alumina eluto was added 100 Fg each of DA and NE. 
~I-I-DA and 3H-NE were separated via column chromatography (Taylor and Laverty, 
1969). 
AmThetamine and Amphetamine Metabolites. Pellet and brain d-amphetamine 
levels were determined by the method of Axelrod (1954). ~H-d-amphetamine and 
8H-d-amphetamine metabolites were determined essentially as described by 
Thoenen et al. (1966). 
In experiments involving 3H material, a zero time blank was prepared by 
adding a known amount of 8H-substance to a brain homogenate and carrying 
through all procedures. Statistical analysis was performed using the student's t-test 
(two-tailed). 
Results 
Relationship o/Motor Activity, Brain Catecholamine Levels 
and Amphetamine Levels after d-Amphetamine Pellet Implantation 
The t ime  course of  changes in amine  levels and  m o t o r  a c t i v i t y  a f te r  
pel le t  ~ i m p l a n t a t i o n  is g iven in  Fig.  1. Animals  in these and  subsequen t  
exper imen t s  were i m p l a n t e d  only  a t  9 A.M. in o rder  to  minimize  the  
effects of  c i rcadian  r h y t h m s  in ca techolamine  levels and  m o t o r  ac t iv i ty .  
The  d a t a  in  Fig.  1 i l lus t ra te  t h a t  t he  m a x i m u m  deple t ion  of  b ra in  D A  
(54~ and  b ra in  N E  (71 ~ ) occurred 4 and  6 h af ter  pel le t  imp lan t a t i on ,  
respect ive ly .  The  levels of  bo th  D A  and  N E  r e tu rned  to  nea r ly  no rma l  
values  wi th in  12 to  14 h, b u t  comple te  recovery  was no t  observed  even 
b y  24 h. Motor  a c t i v i t y  was increased  for the  first 2 to  4 h, g r adua l l y  
decl ined over  the  n e x t  14 h, and  f inal ly a m a r k e d  depression of  a c t i v i t y  
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Fig. 1. Relation of brain d-amphetamine and cat~cholamine levels and motor activity 
as a function of time of pellet implantation. The graph shows the relation of cerebral 
d-amphetamine levels and disappearance of d-amphetamine from the pellet to 
motor activity and brain biogenie amines for 9 A.I~. implanted animals. Amine 
levels are expressed in mean :k S.E. in ~g/g except for the pellet which is in ~g. 
Motor activity was measured using the Pharmacia ]~]P 40 Fc motility meter for a 
5 rain trial at various times after implantation. Activity data is expressed in mean 
counts ~ S.E./5 rain. N~-10--12 animals/group 
was observed 2 4 h  after implantation. Brain d-amphetamine levels 
rapidly increased with a level of 84 ~g/g being measured 2 h after 
implantation. However, by  24 h after implantation, no d-amphetamine 
was detectable in the brain or in the pellet. Despite the initial high level 
of  d-amphetamine, deaths were observed in only 2 to 5~ of the animals 
implanted. 
Tolerance to d-Amphetamine 
Since at  24 h after pellet implantation, no d-amphetamine was de- 
tect~ble in the brain or the pellet, this t ime was used to assess whether 
or not  tolerance had developed to the effects of a subsequent dose of 
d-amphetamine on activity. Two methods of measuring motor  activity 
were employed. When the act ivi ty meter  was used, the activity measured 
was not only exploratory activities but  also stereotyped short distance 
locomotive behaviors located primarily a t  the ends of the act ivi ty arena. 
The lat ter  behavior has been described in detail by  other investigators 
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Fig. 2. Effect of d-amphetamine on activity in pellet implanted animals (photocell 
device). Twenty-four hour pellet implanted animals were administered various 
doses of d-amphetamine i.p. and motor activity was measured for 1 h using a 
Pharmaeia I~/P 40 Fc motility meter. Data is expressed as (counts/5 min) • 10 -1. 
N = 8-- 10 animals/group 
(Lat, 1965; Randrup and Munkvad, 1970). The second measure of 
act ivi ty employed the open field apparatus where the animals were 
scored for both ambulat ion and rearing movements.  
Fig. 2 illustrates tha t  the 24 h implantat ion of a single pellet poten- 
t iated the effects of challenging doses of 3 and 10 mg/kg but  not 
30 mg/kg of d-amphetamine on activity when the photocell device was 
used. This potentiation of effect seemed to exhibit an inverse dose- 
response relationship with 3 mg/kg showing greater potentiation than  
10 mg/kg. In  some experiments, d-amphetamine was administered to 
232 R.J. Hitzemann et al.: 
m ~ CONTROL + AMPHETAMINE 
1 PELLET +AMPHETAMINE. 
~ 2 PELLETS +AMPHETAMINE 
35- 
30-  







40 -  
5 15 30 45 60 
min after  d-amphetamine 
Fig. 3. Effect of multiple pellet implantation on the activity induced by a challenging 
dose of d-amphetamine. Animals were implanted with a single d-amphetamine 
pellet daily for 3 days. Twenty-four hours after each implantation the animals were 
administered a challenging dose of d-amphetamine (3 mg/kg) i.p. Control animals 
implanted with multiple placebo pellets showed little difference in activity after 
implantation and the data from this group was pooled. Activity was measured as 
described in the legend to Fig.2. N = 6--8 animals/group 
24 h pellet implanted animals in doses up to 80 mg/kg. While the animals 
were able to tolerate these high doses fairly well, a second peak of in- 
creased motor  activity was not observed. Since the d-amphetamine 
disappeared from the pellet fairly rapidly, i t  was considered possible 
tha t  only more prolonged d-amphetamine levels or repeated pellet im- 
plantation would produce tolerance. Fig.3 demonstrates tha t  when 
animals were implanted with additional pellets 24 h after the first and 
so on, tolerance still did not develop to a challenging dose of 3 mg/kg 
on activi ty nor was the potentiating effect reversed. 
Tolerance was observed when the open field test  was employed. 
Fig. 4 illustrates tha t  the 24 h implantation of a single pellet produced 
a four-fold tolerance to the effects of subsequent doses of d-amphetamine 
on open field activity. The tolerant animals exhibited a bell-shaped dose- 
response curve as did the controls with the max imum effective dose for 
increasing activity being 40 mg/kg. Stereotyped behavior developed 
more rapidly in the pellet implanted animals with the total  t ime spent 
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Fig.4 Effect of d-amphetamine on open field activity in pellet implanted animals. 
Twenty-four hour pellet implanted animals were administered various doses of 
d-amphetamine i.p. One hour later, the animals were given a single 90 sec trial in 
the open field. The lower graph shows the effect of pellet implantation plus chal- 
lenging doses of d-amphetamine on stereotyped behavior. Stereotyped behavior 
was scored as the time during the 90 sec trial the animals were engaged in highly 
repetitive activities. One count was accumulated for every square crossed and/or 
every rearing movement. Data is expressed as mean counts/min • S.E. The upper 
graph shows the effect of this treatment on motor activity as measured in the open 
field. N = 10 -- 15 animals/group 
in these activities being significantly greater  after challenge doses o f  
3 and 10 mg/kg  of  d-amphetamine.  The m a x i m u m  time spent in stereo- 
typed  behavior  was, however,  no t  significantly different between the  
pellet and control groups. Interest ingly,  a decrease in s tereotyped 
behavior  was observed a t  those doses of  d-amphetamine which caused 
increased open field ac t iv i ty  in the pellet implanted animals. Al though 
the  doses of  d-amphetamine  used in the  open field experiments were 
fairly large, the  mor ta l i ty  ra te  was less than  5 %  and overt  signs of  
d-amphetamine  toxici ty  were rarely observed. 
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E//ect o/ Pellet Implantation on Drug Disposition and Metabolism 
The effects of 24 h pellet implantation on the various activity mea- 
sures (Figs.2--4) might be the result of differences in brain drug levels 
or a shift in the metabolism of d-amphetamine from oxidative deamina- 
~ion to p-hydroxylation with the consequent accumulation of the false 
transmitter p-hydroxynorephedrine in the brain (Smith and Dring, 1970; 
Dring et al., 1966; Goldstein and Anagnoste, 1965). In order to examine 
these possibilities, animals were administered 10 mg/kg of all-d-amphet- 
amine (specific activity 1 ~Ci/mg) i.p. 24 h after implantation. One hour 
later, the animals were sacrificed and the brains analyzed for all-d-am- 
phetamine and for all-d-amphetamine metabolites. Cerebral all-d-am- 
phetamine levels were identical in control and pellet mice. No 8H-nor- 
ephedrine, all-p-OH-amphetamine or aH-p-OH-norephedrine was found 
in the brains of either the pellet implanted or control groups. 
E//ect o/ Pellet Implantation on the Conversion o/ aH-Tyrosine 
to aH-Catecholamines 
Several reports (Sulser et aL, 1968; Hanson, 1967; Weissman et aL, 
1965) have suggested that d-amphetamine increases motor activity by 
potentiating the action of the newly-synthesized brain eateeholamines 
primarily in subeortical structures (Fuxe and Ungerstedt, 1970). There- 
fore, it was of interest to examine the effects of pellet implantation and 
pellet implantation plus a challenging dose of d-amphetamine on brain 
catecholamine synthesis. Implanted animals were administered either 
saline or d-amphetamine (10 mg/kg) i.p. 0.5 h prior to the i.v. injection 
of 1 ~Ci/g body weight of aH-tyrosine (specific activity 11.4 Ci/mmol). 
Animals were sacrificed 15 and 30 rain later and the levels of endogenous- 
and 8H-tyrosine, NE and DA were determined in the diencephalon- 
midbrain-brain stem (DMB). 
The administration of 10 mg/kg of d-amphetamine i.p. 24 h after 
pellet implantation produced a significant decrease in the levels of DA 
and NE in the DMB (Table 1). In contrast, the levels of DA and NE 
showed a small but non-significant increase in control animals. 
Fig. 5 illustrates the effects of various drug treatments on tyrosine 
specific activity and the levels of catecholamine radioactivity. In control 
animals, d-amphetamine significantly increased the accumulation of 
3H-DA but had no effect on aH-NE levels. Twenty-four hour pellet 
implantation alone increased aH-DA levels at 15 rain 40~ (p~0.05) 
and 130~ (p ~ 0.05) at 30 rain. In this group, 3H-NE levels were signif- 
icantly increased at 15 rain only. These effects of pellet implantation 
on 3H-eatecholamine accumulation were partially reversed by the 
administration of d-amphetamine. 
As noted in Fig. 5, tyrosine specific activity was significantly altered 
by 24 h pellet implantation. A useful calculation for incorporating the 
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Table 1. Effect of various drug treatments on the levels of endogenous DA, NE 
and tyrosine in the mouse brain dieneephalon-midbrain and brain stem a 
~ o ~  T ~  DA ~-E 
(~g/g 4- S.E.) 
Control 29.5 4- 1.0 0.63 4- 0.07 0.42 • 0.03 
d-Amphetamine 10 mg/kg 28.0 -[- 1.5 0.75 4- 0.05 0.51 4- 0.06 
Pellet 25.5 4- 1.4 0.72 • 0.04 0.50 4- 0.04 
Pellet -4- d-amphetamine 
10 mg/kg 27.3 =]= 1.1 0,55 ~= 0.05* 0.38 ~ 0.03* 
a The schedule of drug administration is given in the legend to Fig. 5. Data is 
taken from 30 rain after 8H-tyrosine administration. All data expressed as mean 
tzg/g ~ S.E. 
* Significantly different than the pellet control. 20 < 0.05. 
Table 2. Effect of various drug treatments on the conversion 
of aH-tyrosine to 3H-ea~eeholamines 
Group Time Conversion index a 
DA NE 
(m~mol/g/min 4- S.E.) 
Control 15 0.08 4- 0.01 0.06 q- 0.01 
30 0.14 4- 0.01 0.13 4- 0.02 
d-Amphetamine 10 mg/kg 15 0.12 4- 0.01 0.06 4- 0.01 
30 0.19 4- 0.02* 0.11 4- 0.01 
Pellet 15 0.16 • 0.03* 0.13 4- 0.02* 
30 0.61 4- 0.07* 0.21 4- 0.02* 
Pellet q- d-Amphetamine 10 mg/kg 15 0.15 4- 0.03 0.11 4- 0.02 
30 0.16 4- 0.03 0.12 4- 0.02 
a The schedule of drug and SH-tyrosine administration is given in the legend to 
Fig. 5. The details of the calculation of the conversion index are given in the text. 
* Significantly different than control, Io < 0.05. 
t y p e  of  change into  t he  eva lua t ion  of  drug  effects on aH-ca techolamine  
(CA) accumula t ion  is the  convers ion index  (CI) (Cheney et al., 1971) where  
CA (dpm/g) 
G I =  tyrosine (dpm/mumol) • t 
and  t is t he  t ime  a f te r  8H-tyrosine  admin i s t r a t ion .  The  QI values  for the  
var ious  d rug  t r e a t e d  groups  are  given in Table  2. The  CI was increased  
330~ for 3I-I-DA and  61~ for 3H-NE in t he  pe l le t  group a t  3 0 r a i n  
af te r  8H-tyrosine  admin i s t r a t ion ,  d - A m p h e t a m i n e  antagonizes  the  in- 
creased CI values  obse rved  in the  24 h pel le t  an imals  b u t  increases  t he  
CI for D A  in control  animals .  
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Fig. 5. Effect of penet implantation phm d-amphetamine on DA, ~TE and ~ levels 
in the subcortex. Twenty-four hour pellet implanted animals were administered 
10 mg/kg d-amphetamine i.p. 0.5 h prior to the injection of 1 ~zC/g of SH-tyrosine i.v. 
Animals were sacrificed 15 and 30 rain later and the levels of endogenous- and 
aH-Tyr, DA and NE were determined in the dieneephalon-midbrain-brain stem. 
aH-DA and aH-NE levels are given as (dpm/g =]= S.E.) • 10 -~. Tyrosine data is 
presented as specific activity (dpm/m~mol ~ S.E.) • 10 -3. * Significantly different 
than control; ~o ~ 0.05; N ~ 5--  6 determinations/group 
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Discussion 
Of the two methods used to measure activity, only the open field test 
showed that tolerance had developed after pellet implantation to the 
psychomotor stimulant effects of d-amphetamine. The open field differs 
from the mechanical measure of activity employed in the present study 
in that primarily the effect of d-amphetamine on exploratory behaviors 
was measured (Holland et al., 1966). As confirmed in these experiments, 
others have shown that acute d-amphetamine treatment increases the 
performance of rats subjected to the open field by causing a generalized 
increase in exploratory locomotor behavior with facilitation of the inter- 
mittent exploratory rearing response (Gupta et at., 1971; Gupta and 
Holland, 1972; Holland et al., 1966). Furthermore, the arrangement of 
the open field is such that the irrelevant stereotyped locomotor (Lat, 
i965; Randrup and Munkvad, t970) and non-locomotor (Randn~p and 
Munkvad, 1970) behaviors often observed after d-amphetamine admin- 
istration are not scored as part of the ambulation and rearing movements. 
Unlike the open field test, the measurement of activity with the 
photocell device cannot accurately discern between exploratory and 
stereotyped activities. In some experiments, we attempted to circumvent 
this problem by reducing the number of photocells (see Methods). 
However, stereotyped behaviors occurring in the region of even a single 
medial row of photocells intefferred with the accurate measurement of 
the animals' exploratory activities. The potentiation of activity measured 
by the counting device when the pellet implanted animals are challenged 
with d-amphetamine is, nonetheless, an interesting phenomenon. These 
data qualitatively confirm the finding that the dose-response curve for 
stereotyped behavior is shifted to the left after pellet implantation. 
The biochemical mechanism underlying the pellet-induced shift in 
the open field dose-response curve for exploratory activity is presently 
unclear. The increase in activity observed in the pellet implanted animals 
after challenging doses of 40 to 50 mg/kg of d-amphetamine is not 
sensitive to reserpine and/or ~-methyltyrosine pretreatment (unpublished 
observations) suggesting that d-amphetamine is no longer acting in- 
directly via the brain eatecholamines. Perhaps a direct interaction be- 
tween the drug and noradrenergie and/or dopaminergic receptors should 
be considered. 
Of more pertinent pharmacologic interest, at least in terms of the 
doses employed, is the mechanism by which pellet implantation poten- 
tiates the ability of low doses of d-amphetamine to produce stereotyped 
behavior. Fuxe and Ungerstedt (1970) have presented evidence that 
exploratory activity is related to an increase in noradrenergic receptor 
activity in the hypothalamus and limbic system while the stereotyped 
behaviors can be attributed to an activation of brain dopaminergic 
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neurons in the neostriatum (Randrup and Munkvad, 1970). From these 
data, the authors have postulated that the ratio of DA to NE receptor 
activity will determine the nature of the animal's response to d-amphet- 
amine. Using this model, one would conclude that in pellet implanted 
animals receiving challenging low doses of d-amphetamine the ratio of 
DA to NE receptor activity increases. 
To test this hypothesis, the effect of pellet implantation plus chal- 
lenges of d-amphetamine on the cerebral conversion of 3H-tyrosine to 
3H-cateeholamines and on changes in endogenous catecholamine levels 
was examined. Costa and Groppetti (1970) and Persson (1969) have 
shown that acute d-amphetamine treatment increases the conversion of 
a pulse label 8H-tyrosine to 8H-DA but not 8H-NE in the rat brain. 
The present study confirms that this effect also occurs in the mouse 
brain. This increased conversion to 8H-DA is thought to represent an 
increase in brain DA turnover (Costa and Groppetti, 1970). Pellet im- 
plantation apparently effected an accumulation of d-amphetamine's 
actions on brain DA. In 24 h implanted animals, the CI for DA was 
increased 330~ while the CI for NE was increased only 61~ If  an 
increase in conversion truly is representative of an increase in turnover 
and, consequently, an increase in transmitter release, these data would 
suggest that the ratio of DA/NE receptor activity is increased after pellet 
implantation. These data may help to explain the increase in stereotyped 
behavior in pellet implanted animals receiving no additional d-amphet- 
amine (see Fig.4). 
In 24 h pellet implanted animals administered 10 mg/kg of d-am- 
phetamine, no change from control was observed in the conversion of 
3H-tyrosine to 8H-catecholamines. The mechanism by which a single 
injection of d-amphetamine can reverse the increased conversion observed 
in the pellet controls is thought to be related to the rapid decrease in 
endogenous cateeholamine levels (Table 1). This attenuated mobilization 
of catecholamines from intraneuronal storage vesicles could reverse the 
increase in 8H-eatecholamine synthesis by increasing the levels of 
eatecholamines in the nerve-ending eytosol which competes with the 
reduced pteridine co-factor for the oxidized tyrosine hydroxylase (Ikeda 
et al., 1966; Kopin et al., 1968; Weiner et al., 1972). 
These data suggest that in pellet implanted animals receiving a 
challenge dose of d-amphetamine, the ratio of DA to NE synthesis is 
similar to control and would argue against the hypothesis that the ratio 
of DA to NE receptor activity is increased in this group. In what manner 
the increase in the release of both endogenous DA and NE may contribute 
to the increase in stereotyped over exploratory behaviors remains to be 
determined. 
The present study demonstrates that pellet implantation may be 
useful in rapidly producing tolerance to at least one d-amphetamine 
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induced  behavior ,  n a m e l y  exp lo ra to ry  behavior ,  b u t  is no t  useful  when 
o the r  behaviors  such as s t e r eo typed  a c t i v i t y  are  examined.  The  impor t -  
ance of  using a t  leas t  more  t h a n  one m e t h o d  to assess to lerance  develop-  
m e n t  was also emphasized.  F u r t h e r m o r e ,  the  p resen t  s t u d y  suggests  
t h a t  chronic d - amphe t amine  t r e a t m e n t  po ten t i a t e s  the  ab i l i ty  of  sub- 
sequent  "pha rmaco log ica l "  doses of  t he  drug  to  produce  s t e r eo typed  
behavior .  
This work was supported in part by USPHS Grants MH-11846 (EFD) and 
MH-20559 (HHL). 
References 
Anton, A. H., Sayre, D. F.:  A study of factors affecting the aluminium oxide- 
trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. 
exp. Ther. 138, 360--375 (1962). 
Ansell, G. B., Beeson, M. F. : A rapid and sensitive procedure for the combined 
assay of noradrenaline, dopamine and serotonin in a single brain sample. Analyt. 
Bioehem. 23, 196--206 (1968). 
Axe]rod, J. : Studies on sympathetic amines. II .  The biotransformation and physio- 
logical disposition of d-amphetamine, d-P-hydroxyamphetamine and d-meth- 
amphetamine. J. Pharmacol. exp. Ther. 110, 315--326 (1954). 
Brodie, B. B., Cho, A. K., Stefano, F. J. E., Gessa, G. L.: On mechanisms of nor- 
adrenaline release by amphetamine and tyramine and tolerance to their effects. 
In: Advances in biochemical psychopharmacology (E. Costa and P. Greengard, 
Eds.), pp. 219--238. New York: Raven Press 1969. 
Cheney, D. L., Goldstein, A., Algeri, S., Costa, E. : Narcotic tolerance and depend- 
ence: Lack of relationship with serotonin turnover in the brain. Science 171, 
1169--1170 (1971). 
Costa, E., Groppetti, A. : Biosynthesis and storage of eatecholamines in tissues of 
rats injected with various doses of d-amphetamine. In: Amphetamines and 
related compounds (E. Costa and S. Garattini, Eds.), pp. 231--256. New York: 
Raven Press 1970. 
Dring, L. G., Smith, R. L., Williams, R. T. : The fate of amphetamine in man and 
other mammals. J. Pharm. Pharmaeo]. 18, 402--405 (1966). 
Fuxe, K., Ungerstedt, U.: Histochemical, biochemical and functional studies on 
central monoamine neurons after acute and chronic amphetamine administra- 
tion. In: Amphetamines and related compounds (E. Costa and S. Garattini, 
Eds.), pp. 257--288. New York: Raven Press 1970. 
Goldstein, ~I., Anagnoste, B. : The conversion in rive of d-amphetamine (~-)p-hy- 
droxynorephedrine. Biochim biophys. Acta (Amst.) 107, 166 (1965). 
Gupta, B. D., Dandiya, P. C., Gupta, M. L., Gabba, M. K.: An examination of the 
effect of central nervous system stimulant and antidepressant drug on open- 
field performance in rats. Europ. J. Pharmacol. 1S, 341--346 (1971). 
Gupta, B. C., Holland, H. C. : Emotion as a determinant of the effects of drugs 
and their combination on different components of behavior in rats. Neuro- 
pharmacology 11, 31--38 (1972). 
Hanson, L. C. F. :  Evidence that the central action of (+)-amphetamine is mediated 
via catecholamines. Psyehopharmaeologia (Berl.) 10, 289--296 (1967). 
Harrison, J. W. E., Ambrus, C./K., Ambrus, J. L. : Tolerance of rats toward am- 
phetamine and methamphetamine. J. Amer. pharm. Ass. 41, 539--541 (1952). 
ttitzemann, R., Loh, H. : Tolerance to amphetamine-induced psychomotor stimula- 
tion in mice. Prec. West. Pharmaeol. Soc. 15, 110--113 (1972). 
Hitzemann, R., Loh, H.: Effect of p-hydroxynorephedrine on brain cateehol- 
amine synthesis. J. Pharmacol. (1972). 
240 R. J. HRzemann e~ al.: d-Amphetamine Pellet Implantation 
Holland, H. C., Gupta, B. D., Weldon, E.: A note on rearing and on environ- 
mental constraint. Activ. herr. sup. (Praha) 8, 140--144 (1966). 
Hollinger, M.: Effect of reserpine, c~-methyl-p-tyrosine, p-ehlorophenyl-alanine and 
pargyline on levorphanol-induced running activity in mice. Arch. int. Phar- 
macodyn. 179, 419--424 (1969). 
Ikeda, M., Fahien, L. A., Udenf1'iend, S. : A kinetic study of bovine adrenal tyro- 
sine hydroxylase. J. biol. Chem. 241, 4452--4456 (1966). 
Kalant, O. J.:  The amphetamines. University of Toronto Press, Toronto 1966. 
Kasman, M. E., Unna, K. R.: Effects of the chronic administration of amphet- 
amine and other stimulants on behavior. Clin. Pharmacol.Ther. 9, 240--254 (1967). 
Kopin, I, J., Breese, G. R., Kranss, K. R., Weise, V. K. : Selective release of newly 
synthesized norepinephrine from the cat spleen during sympathetic nerve 
stimulation. J. Pharmaeol. exp. Ther. 161, 271--278 (1968). 
Lat, J. :  The spontaneous exploratory reactions as a tool for psyehopharmaeologic 
studies. Prec. 2nd Intern. Pharmacol. Meeting (Czechoslovak Medical Press, 
Praha), pp. 47--66 (1965). 
Lewander, T. : A mechanism for the development of tolerance to amphetamine in 
rats. Psychopharmacologia (Berl.) 21, 17--31 (1971). 
I~ewton, G., Levine, S. : Early experience and behavior, p. 152. Springfield, Ill. : 
Ch. C. Thomas 1968. 
Persson, T.: Drug induced changes in 3H-eateeholamine accumulation after 8H- 
tyrosine. Acta pharmaeol. (Kbh.) 28, 378--390 (1970). 
Randrup, A., Munkvad, I. : Biochemical, anatomical and psychological investiga- 
tions of stereotyped behavior induced by amphetamines. In: Amphetamines 
and related compounds (E. Costa and S. Garattini, Eds.), pp. 695--715. New 
York: Raven Press 1970. 
Smith, R. L., ])ring, R. G.: Patterns of metabolism of fl-phenylisopropylamines in 
man and other species. In: Amphetamines and related compounds (E. Costa 
and S. Garattini, Eds.), pp. 121--140. New York: Raven Press 1970. 
Sulser, F., Owens, M.L., Norvich, M.R., Dingell, J .V. :  The relative role of 
storage and synthesis of brain norepinephrine in the psychomotor stimulation 
evoked by amphetamine or by desipramine and tetrabenazine. Psyehopharmaco- 
logia (Berl.) 12, 322--332 (1968). 
Taylor, K. M., Laverty, R. 9 The metabolism of tritiated dopamine in regions of 
the rat brain in vivo. I. The separation of catecholamines and their metabolites. 
J. Neuroehem. 16, 1361--1366 (1969). 
Thoenen, H., Hurlimann, K. F., Gey, K. F., Haefly, W. : Liberation of p-hydroxy- 
norephedrine from cat spleen by sympathetic nerve stimulation after pretreat- 
ment with amphetamine. Life Sci. 5, 1715--1722 (1966). 
Weiner, N., Rabadjija, M.- The effect of nerve stimulation on the synthesis 
and metabolism of norepinephrine in the isolated gninea-pig hypogastric 
nerve--vas deferens preparation. J. Pharmaeol. exp. Ther. 160, 61--71 (1968). 
Weissman, A., Koe, B.K., Tenen, S. S.: Antiamphetamine effects following in- 
hibition of tyrosine hydroxylase. J. Pharmaco]. exp. Ther. 151, 329--352 (1966). 
Horare H. Loh, Ph.D. 
Department of Pharmacology 
School of Medicine 
University of California 
Medical Center 
San Francisco, California 94122, U.S.A. 
